Correspondence 0001903596-23-000018 from Emergent Health Corp. (EMGE) (CIK 0001463459)
Emergent Health Corp. (EMGE) (CIK 0001463459)
Date: Jan. 5, 2023 · CIK: 0001463459 · Accession: 0001903596-23-000018
AI Filing Summary & Sentiment
File numbers found in text: 024-11708
Letter
VIA EDGAR Office of Trade & Services Division of Corporation Finance Securities and Exchange Commission Post-qualification Amendment No. 2 (the “Post-Qualification Amendment”) Filed January 3, 2023 Commission File No. 024-11708
Dear Ms. Beysolow:
On behalf of the Company, I respectfully request that the qualification date of the Post-Qualification Amendment be accelerated and that the Post-Qualification Amendment be declared qualified Friday, January 6, 2023, at 4:00 p.m. EST, or as soon thereafter as is reasonably practicable.
In making this request, the Company represents that the Post-Qualification Amendment will be approved in the State of New York, upon qualification by the Securities and Exchange Commission (the “Commission”), and acknowledges the following:
- should the Securities and Exchange Commission (the “Commission”) or the Staff, acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action with respect to the filing;
- the action of the Commission or the staff, acting pursuant to delegated authority, to declare the filing qualified does not relieve the Company from its full responsibility for the adequacy and accuracy of disclosure in the filing; and
- the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities law of the United States.
Very
truly yours,
/s/
James Morrison
Show Raw Text
CORRESP
1
filename1.htm
Emergent
Health Corp.
150
Motor Parkway, Suite 401
Hauppauge,
New York 11787
January
5, 2023
VIA
EDGAR
Ms.
Jennie Beysolow
Office
of Trade & Services
Division
of Corporation Finance
Securities
and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Re: Emergent
Health Corp. (the “Company”)
Offering
Statement on Form 1-A
Post-qualification
Amendment No. 2
(the
“Post-Qualification Amendment”)
Filed
January 3, 2023
Commission
File No. 024-11708
Dear
Ms. Beysolow:
On
behalf of the Company, I respectfully request that the qualification date of the Post-Qualification Amendment be accelerated and that
the Post-Qualification Amendment be declared qualified Friday, January 6, 2023, at 4:00 p.m. EST, or as soon thereafter as is reasonably
practicable.
In
making this request, the Company represents that the Post-Qualification Amendment will be approved in the State of New York, upon qualification
by the Securities and Exchange Commission (the “Commission”), and acknowledges the following:
- should
the Securities and Exchange Commission (the “Commission”) or the Staff, acting pursuant to delegated authority, declare the
filing qualified, it does not foreclose the Commission from taking any action with respect to the filing;
- the
action of the Commission or the staff, acting pursuant to delegated authority, to declare the filing qualified does not relieve the Company
from its full responsibility for the adequacy and accuracy of disclosure in the filing; and
- the
Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under
the federal securities law of the United States.
Very
truly yours,
/s/
James Morrison
James
Morrison
Chief
Executive Officer
Emergent
Health Corp.